MISOFAR

MISOFAR 25 mcg N8 vaginal tablets

Composition:

Misoprostol

Dosage:

Misoprostol 25 mcg

Cod ATC:

G02AD06

Therapeutic indications:

MISOFAR 25 is a synthetic prostaglandin E₁ indicated in obstetrics and gynecology, including medical management of miscarriage, induction of labor, cervical ripening before surgical procedures, and in the treatment of postpartum hemorrhage.

Description:

MISOFAR vaginal tablets is the only pharmaceutical form of misoprostol, used in obstetrics and gynecology. Clinical efficacy of misoprostol in vaginal tablets increases compared with other forms, assuring a constant plasma concentration, while decreasing the side effects specific to misoprostol products.

Manufacturer

BIAL – Portela & Cª À Avenida da Siderurgia Nacional, 4745-457 Coronado (S. Romão e S. Mamede), Portugal

Pharmacovigilance

Information about drug safety

Pharmacovigilance is the science and activities related to the detection, evaluation, understanding and prevention of adverse effects or any other problem related to medicines.